ReviewPathogens (Basel, Switzerland)2026
An Overview of Epidemiological Tools That Support the Progress of Foot-and-Mouth Disease Control in Southeast Asia.
Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Foot-and-mouth disease (FMD) causes significant losses for livestock farmers in affected countries and regions, including Southeast Asia, where several countries are progressing through different stages of the Progressive Control Pathway (PCP) under diverse resource settings. The PCP, developed by the World Organization for Animal Health and the Food and Agriculture Organization of the United Nations, is an outcome-oriented strategy designed to support progress toward the elimination of FMD. In this review paper, we propose an evidence-based framework linking epidemiological tools to each PCP stage requirements based on studies conducted in eight Southeast Asian countries through peer-reviewed research and gray literature. The findings indicate that Stage 1 progression is supported through risk-factor analyses, seroprevalence studies, and participatory epidemiology, while Stage 2 relies on spatial analyses and evaluations of control strategies. Progression to Stage 3 requires evidence of active surveillance systems for rapid detection of new viral incursions, whereas later stages depend on risk assessment, sustained surveillance, and restricting transboundary animal movement. Regional challenges include underreporting, surveillance-system deficiencies, and inconsistent vaccination monitoring. The framework proposed herein provides a practical approach for aligning the generation of evidence with PCP requirements. Ultimately, strengthened regional collaboration that coordinates transboundary risk management is crucial for progress toward sustainable FMD control in Southeast Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.